(DMII - DRUGS MADE IN AMERICA ACQUISITION II CORP.)

company profile

Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Drugs Made In America Acquisition Ii (DMII) is trading at 10.195

Open Price
10.19
Previous close
10.195
Previous close
10.195
P/E Ratio
12.6159
Shares outstanding
63700000
Primary exchange
NASDAQ-NMS
ISIN
KYG2851K1040